{
  "slug": "cannformatics",
  "name": "Cannformatics",
  "description": "Cannformatics delivers predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life. The company uses proprietary Cannabis-Responsive™ (C-Res™) biomarker technology and an AI-powered cannabinoid-based pharmacometabolomics approach to personalize medical cannabis treatment, focusing initially on neurological and neuropsychiatric disorders like autism and dementia.",
  "url": "https://optimly.ai/brand/cannformatics",
  "websiteUrl": "https://cannformatics.com/",
  "logoUrl": "https://logo.clearbit.com/cannformatics.com",
  "baiScore": 55,
  "bai_tier_status": "active",
  "bai_score_status": "active",
  "archetype": null,
  "archetype_status": "active",
  "category": "AI Clinical Decision Support Platforms",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [],
  "competitorsProse": null,
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-09-19T18:17:45.374Z",
  "verifiedVitals": {
    "website": "https://cannformatics.com",
    "category": "Biotechnology / Medical Cannabis Research / AI in Healthcare",
    "what_it_does": "Cannformatics aims to personalize medical cannabis treatment by delivering predictable and repeatable science-based outcomes to improve health and quality of life. They achieve this through their proprietary Cannabis-Responsive™ (C-Res™) biomarker technology, which measures metabolic biomarkers in saliva to quantify individual responses to cannabis. Their AI-powered cannabinoid-based pharmacometabolomics approach and bioinformatics platform guide users to optimal medical cannabis treatments, including products, dosages, and consumption methods.",
    "primary_audience": "Cannformatics partners with healthcare providers (HCPs) who recommend cannabis to their patients. Their focus areas include children with autism and dementia patients, with plans to expand to anxiety, pain, neurodegenerative diseases, and nausea.",
    "core_product": "The core product is their Cannabis-Responsive™ (C-Res™) biomarker technology and bioinformatics platform. This technology identifies and applies biomarkers found in saliva to personalize medical cannabis treatment. They are also launching lab services to tailor medical cannabis treatment for conditions like dementia and migraine."
  },
  "intentTags": null,
  "businessProfileClaims": [],
  "timestamp": 1790031578697
}